AB BioTechnologies, a drug-development services company located in Bloomington, Indiana, has announced plans to add contract manufacturing operations in Bloomington, creating up to 33 new jobs by 2020. The company has said it will invest $10.5 million to construct and equip a 23,000-square-foot facility at the site.

AB BioTechnologies will launch clinical manufacturing services at the new facility. This will include a manufacturing area for formulating, filling, lyophilizing, and packaging drugs for early-phase clinical trial studies. The company will also be relocating its warehouse and development laboratory to the facility, moving from its current 1,950-square-foot building to the new facility in Bloomington. With construction scheduled to begin this spring, the company plans to open the new facility in November 2017. The company plans to begin hiring early this year for technical and support positions.

Founded in 2008 as a teaching and consulting firm, AB BioTechnologies has expanded into developing and optimizing drug development for the pharmaceutical industry. The company performs pre-formulation and formulation development and optimizes lyophilization cycles, offering differential scanning calorimetry, freeze-dry microscopy, and lyophilization cycle scale-up and transfer.

The Indiana Economic Development Corporation offered AB BioTechnologies up to $290,000 in conditional tax credits and up to $30,000 in training grants based on the company’s job-creation plans. These incentives are performance-based, meaning that until Indiana residents are hired, the company is not eligible to claim incentives. Monroe County is considering additional incentives at the request of the Bloomington Economic Development Corporation.

Source: AB BioTechnologies